Logo do repositório
 
Miniatura
Publicação

Predictors of ACEI/ARB therapy in patients with hypertrophic cardiomyopathy : results of a national registry

2018Artigo científico Acesso aberto
http://hdl.handle.net/10451/40136
Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
P3544.pdf362.22 KBAdobe PDF Ver/Abrir

Autores

Martins, E.
Lebreiro, A.
Sousa, C.
Leite, S.
Sousa, A.
Belo, A.
Cardim, N.

Orientador(es)

Resumo(s)

Introduction: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) are not considered disease-modifying drugs in hypertrophic cardiomyopathy (HCM) and their use is usually dependent on other clinical indications. Few data exist about the use of ACEI/ARB in HC in the real world, particularly in patients with intraventricular obstruction. Objective: In this study, we sought to determine the frequency of ACEI / ARB therapy in patients with HCM and the predictors for their use.

Descrição

© The European Society of Cardiology 2018. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Palavras-chave

Angiotensin-converting enzyme inhibitors Hypertrophic cardiomyopathy

URI

http://hdl.handle.net/10451/40136

Contexto Educativo

Citação

European Heart Journal, Volume 39, Issue suppl_1, August 2018, ehy563.P3544

Projetos de investigação

Unidades organizacionais

Fascículo

Editora

Oxford University Press

DOI

10.1093/eurheartj/ehy563.P3544

Coleções

FM-CCUL-Artigos em Revistas Internacionais

Licença CC

cclicense-by

Métricas Alternativas